Synta Pharmaceuticals Corp (NASDAQ:SNTA)

2.45
Delayed Data
As of 10:52am ET
 +0.0301 / +1.24%
Today’s Change
2.18
Today|||52-Week Range
6.69
-7.54%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Synta Pharmaceuticals Corp have a median target of 14.50, with a high estimate of 20.00 and a low estimate of 9.00. The median estimate represents a +491.81% increase from the last price of 2.45.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Synta Pharmaceuticals Corp. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.21
Sales
$0.00
Reporting Date
Mar 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -9.47%
 
 
 
 
 
 
Growthannually 30.24%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account